Rh. Larsen et al., AT-211-LABELING OF POLYMER PARTICLES FOR RADIOTHERAPY - SYNTHESIS, PURIFICATION AND STABILITY, Journal of labelled compounds & radiopharmaceuticals, 33(10), 1993, pp. 977-986
Cyclotron-produced At-211 was distilled from a Bi metal target and cou
pled to N-succinimidyl-3-(trimethylstannyl)benzoate. The resulting N-s
uccinimidyl-3-(At-211)astatobenzoate was thereafter coupled to aminate
d monosized polymer particles with a diameter of 1.8 mum. The total ti
me elapsed from the end of the cyclotron irradiation until the final p
roduct was prepared was about 2.5 hours. From 23 to 51 % of the target
activity at the end of bombardment was measured in the final conjugat
e. Solid-liquid extraction purification of the astatinated intermediat
e, using Sep-pak columns (Waters), gave more reproducible yields in th
e final conjugation step. The At-211-labelled particles were incubated
with fetal calf serum, human serum and human full blood at room tempe
rature. The At-211 activity on the particles was measured before and a
fter three times washing at 4, 24 and 48 hours. The stability was not
significantly different from 100 % for all media and for all time poin
ts. This indicates that At-211-labelled particles can be stable under
in vivo conditions, and may thereby be a promising agent for intracavi
tary radiotherapy on free-floating cancer cells or surface fixed cells
.